Education
About Us
Working with TipRanks
Follow Us
Eledon Pharmaceuticals (ELDN)
NASDAQ:ELDN
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -359.00K | $ -374.00K | $ -373.00K | $ -195.00K | $ -183.00K |
| Operating Income | $ -70.58M | $ -43.00M | $ -39.78M | $ -36.87M | $ -13.28M |
| EBITDA | $ -35.39M | $ -116.16M | $ -87.59M | $ -36.66M | $ -23.03M |
| Net Income | $ -36.18M | $ -116.54M | $ -87.97M | $ -34.51M | $ -22.81M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 140.18M | $ 51.10M | $ 56.41M | $ 84.83M | $ 114.19M |
| Total Assets | $ 177.41M | $ 89.07M | $ 92.79M | $ 170.55M | $ 197.19M |
| Total Debt | $ 954.00K | $ 383.00K | $ 746.00K | $ 769.00K | $ 144.00K |
| Net Debt | $ -19.59M | $ -4.23M | $ -55.66M | $ -84.06M | $ -114.05M |
| Total Liabilities | $ 59.27M | $ 81.86M | $ 8.61M | $ 6.55M | $ 6.59M |
| Stockholders' Equity | $ 118.14M | $ 7.21M | $ 84.18M | $ 164.00M | $ 190.60M |
| Cash Flow | |||||
| Free Cash Flow | $ -47.27M | $ -39.53M | $ -28.42M | $ -28.91M | $ -15.21M |
| Operating Cash Flow | $ -47.27M | $ -39.53M | $ -28.42M | $ -28.91M | $ -15.21M |
| Investing Cash Flow | $ -70.31M | $ -45.29M | $ 0.00 | $ 0.00 | $ 11.04M |
| Financing Cash Flow | $ 133.52M | $ 33.02M | $ 0.00 | $ -449.00K | $ 109.58M |